A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more ...

A new study by the Medical University of Vienna found that a specialized form of imaging could identify 91% of prostate ...

PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...

Adding aglatimagene besadenovec (CAN-2409) to external beam radiation therapy (EBRT) was associated with greater lymphocyte infiltration of prostate tissue and greater lymphocyte- ...

PACE is the first phase 3 randomized trial directly comparing radical prostatectomy with SBRT in men with low- to intermediate-risk prostate cancer.

Fagundes, MD, discussed when proton therapy is most justified over photon approaches in prostate cancer. In an interview with ...

August–September 2026 / bladder cancer, cancer, cancer care, Cancer research, cancer treatment, chemotherapy, clinical trials ...

Fagundes, MD, discussed disease control by risk group among 404 patients with prostate cancer treated with ...

Two New Studies Highlight the Dynamic Meaning of PSA After Prostate Cancer Treatment / Abdenour Nabid, Alison C. Tree, Almudena Zapatero, Amar ...